» Authors » D G Wright

D G Wright

Explore the profile of D G Wright including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 141
Citations 1457
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Weichman K, Dember L, Prokaeva T, Wright D, Quillen K, Rosenzweig M, et al.
Bone Marrow Transplant . 2006 Jul; 38(5):339-43. PMID: 16862166
Light chain deposition disease (LCDD) is caused by a clonal plasma cell disorder in which fragments of monoclonal immunoglobulin light chains form non-fibrillary deposits in various tissues resulting in organ...
12.
Sanchorawala V, Blanchard E, Seldin D, OHara C, Skinner M, Wright D
Am J Hematol . 2006 Jun; 81(9):692-5. PMID: 16795060
AL amyloidosis, a systemic disorder characterized by widespread deposition of amyloid fibrils derived from monoclonal Ig light chains in organs and soft tissues, is typically caused by an underlying plasma...
13.
Sanchorawala V, Seldin D, Magnani B, Skinner M, Wright D
Bone Marrow Transplant . 2005 Jul; 36(7):597-600. PMID: 16044137
Serum free light-chain (FLC) concentrations were measured by a sensitive nephelometric immunoassay in 66 patients with AL amyloidosis before and after treatment with high-dose melphalan and autologous stem cell transplantation...
14.
Oran B, Malek K, Sanchorawala V, Wright D, Quillen K, Finn K, et al.
Bone Marrow Transplant . 2005 Jan; 35(6):567-75. PMID: 15665842
Treatment of patients with AL amyloidosis with high-dose melphalan and autologous peripheral blood stem cells (PBSC) produces hematologic remissions in approximately 40% of evaluable patients, accompanied by improvements in organ...
15.
Sanchorawala V, Wright D, Seldin D, Falk R, Finn K, Dember L, et al.
Bone Marrow Transplant . 2003 Dec; 33(4):381-8. PMID: 14676787
A prospective randomized trial was conducted to study the timing of high-dose intravenous melphalan and autologous stem cell transplantation (HDM/SCT) in AL amyloidosis. In all, 100 newly diagnosed patients were...
16.
Oran B, Wright D, Seldin D, McAneny D, Skinner M, Sanchorawala V
Am J Hematol . 2003 Sep; 74(2):131-5. PMID: 14508801
The frequency of splenic involvement in AL amyloidosis is not precisely known. However, splenomegaly has been reported in 4-13% of patients. We report four cases of spontaneous splenic rupture in...
17.
Akpek G, Lenz G, Lee S, Sanchorawala V, Wright D, Colarusso T, et al.
Bone Marrow Transplant . 2002 Jan; 28(12):1105-9. PMID: 11803350
We prospectively studied absolute lymphocyte (ALC) and monocyte counts (AMC), lymphocyte subsets and proliferative in vitro responses to mitogen and antigen in 12 patients with AL-amyloidosis (AL) undergoing autologous blood...
18.
Sanchorawala V, Wright D, Seldin D, Dember L, Finn K, Falk R, et al.
Bone Marrow Transplant . 2001 Nov; 28(7):637-42. PMID: 11704785
Primary or AL amyloidosis results from a plasma cell dyscrasia in which fibrillar light chain protein deposition leads to organ failure and death. Standard treatment for AL amyloidosis has been...
19.
Engelich G, Wright D, Hartshorn K
Clin Infect Dis . 2001 Nov; 33(12):2040-8. PMID: 11698988
There is evidence that acquired dysfunction of neutrophils, monocytes, or macrophages is an important cause of infection in patients with diabetes mellitus, renal or hepatic failure, alcoholism, autoimmune diseases, influenza...
20.
Akpek G, Lee S, Gagnon D, Cooley T, Wright D
Am J Hematol . 2001 May; 67(2):100-6. PMID: 11343381
Bone marrow (BM) aspiration and biopsy are used commonly in clinical practice to diagnose invasive tissue infections caused by Mycobacterium avium intracellulare (MAC), Mycobacterium tuberculosis (TB), and Histoplasma capsulatum (HC)...